R prostate data

Regular testing is crucial as the cancer needs to be diagnosed before metastasis.

Fast facts on prostate cancer: Here are some key points about the prostate cancer. The prostate gland is part of the male reproductive system. It is treatable if diagnosed r prostate data r prostate data early, before it spreads.

If symptoms appear, they include problems with urination. Regular screening Is the best way to detect it in r prostate data good time.

Symptoms Prostate cancer is the most common cancer affecting men.

Prostate cancer is the most common cancer affecting men. There R prostate data are usually no symptoms during the early stages of prostate cancer. However, if symptoms do appear, they usually involve one or more of the following: Frequent urges to urinate, R prostate data including at night difficulty commencing and maintaining urination blood in the urine painful urination and, less commonly, ejaculation difficulty achieving or R prostate data maintaining an erection may be difficult Advanced prostate cancer can involve the following symptoms: bone r prostate data pain, often in the spine, femur, pelvis, or ribs bone fractures If The cancer spreads to the spine and compresses the spinal cord, there may be: leg weakness urinary incontinence fecal incontinence Treatment Treatment is different for early and advanced prostate cancers. Early stage r prostate data prostate cancer If the cancer is small and localized, it is usually managed by one of the following treatments: Watchful waiting or monitoring: PSA blood levels are regularly checked, R prostate data but there is no immediate action. The R prostate data risk of side-effects sometimes outweighs the need for immediate treatment for this slow-developing cancer. Radical prostatectomy: The prostate is surgically removed.

Traditional surgery requires a hospital stay of up to 10 days, with a recovery time of up to 3 months. Robotic keyhole surgery involves a shorter hospitalization and recovery period, r prostate data but it can be more expensive. Patients should speak to their insurer about coverage. Brachytherapy: Radioactive seeds are implanted into the prostate to deliver targeted radiation treatment. Conformal radiation therapy: Radiation beams are shaped so that the region where they overlap is as R prostate data close to the same shape as the organ or region that requires treatment. This minimizes healthy tissue exposure to radiation.

Intensity modulated r prostate data radiation therapy: Beams with variable intensity are R prostate data used. This is an advanced form of conformal radiation therapy.

In the Early stages, patients may receive radiation therapy combined with hormone therapy for 4 to 6 months. Treatment recommendations depend on individual cases. The patient should R prostate data discuss all available options with their urologist or oncologist.

Advanced prostate cancer Advanced cancer is more aggressive and will have spread R prostate data further throughout the body. Chemotherapy may be recommended, as it can kill cancer cells around the body. Androgen deprivation therapy (ADT), or androgen suppression therapy, is a hormone treatment r prostate data that reduces the effect of androgen.

Androgens are male hormones that can stimulate cancer growth. ADT r prostate data can slow down and even stop cancer growth by reducing androgen levels. The r prostate data patient will likely need long-term hormone therapy. Even R prostate data if the hormone therapy stops working after a while, there may be other options. Participation R prostate data in clinical trials is one option that a patient may wish to discuss with R prostate data the doctor. Radical prostatectomy is not currently an option for advanced cases, as it does not treat the cancer that has spread to other parts of the body.

Fertility r prostate data As the prostate is directly involved with sexual reproduction, removing it affects semen production and fertility. Radiation therapy affects the prostate tissue and often reduces the ability to father R prostate data children. The sperm can be damaged and the semen insufficient for transporting sperm. Non-surgical R prostate data options, too, can severely inhibit a man's reproductive capacity. Options for preserving these functions can include donating to a sperm bank before surgery, or having sperm extracted directly from the testicles for artificial insemination into an egg. However, the success of these options is never guaranteed.

Patients with prostate cancer can speak to a fertility doctor if they still intend to father children.

This means r prostate data that its fluids and secretions are intended for use outside of the body. The prostate produces the fluid that nourishes and transports sperm on their journey to fuse with a female ovum, or egg, and produce human life. The prostate contracts and forces these fluids out during orgasm.

The protein excreted by the prostate, prostate-specific antigen (PSA), helps semen retain its liquid state. An excess of this protein in the blood is one of the first signs of prostate cancer.





Car-t prostate cancer

Prostate stones

Qmax prostate

24.05.2018 - Desant016

The PSA test prostate cancer and medications, catheters and surgery. Reducing complications: Abstract.

24.05.2018 - BALACA_SIRTIQ_USAQ

May order a biopsy to help urine control estimations.

24.05.2018 - xan001

The ability to father children which urine and semen but the American Cancer Society.

Cilexin

R prostate data

Once the cancer metastasizes, or spreads, the 5-year survival rate is 29 percent. Regular r prostate data screening can help detect prostate cancer while r prostate data R prostate data it is still treatable. Risk factors The exact cause of prostate cancer is unclear, but there are many possible risk factors. Age Prostate cancer is rare among men under the age of 45 years, but more common after the age of 50 years. Geography Prostate cancer occurs most frequently in North r prostate data R prostate data America, northwestern Europe, on the Caribbean islands, and in Australia.

Genetic factors Certain genetic and ethnic groups have an increased risk of prostate cancer. In the U. S., prostate cancer R prostate data is at least 60 percent more common and 2 to 3 times more deadly among black men than non-Hispanic white men. A man also has a much higher risk of developing cancer if his identical twin has it, and a man whose brother or father had prostate cancer has twice the R prostate data risk of developing it compared to other men. Having a brother who has or has had prostate cancer is more of a genetic risk than having a father with the r prostate data R prostate data disease. Diet Studies have suggested that a diet high in red meat or high-fat dairy products may increase a person's chances of developing prostate cancer, but the link is neither confirmed nor clear. Medication Some R prostate data research has suggested that non-steroidal anti-inflammatory drug (NSAID) use may reduce the risk of prostate cancer. Others have linked NSAID use with a higher risk of death from the disease. This is a controversial area, and results have not been confirmed. There has also been some investigation into whether statins might slow the progression of prostate cancer. One 2016 r prostate data study concluded that results were "weak and inconsistent." R prostate data Obesity It is often believed that obesity is linked to the development of prostate cancer, but the American Cancer Society maintains that there is no clear link. Some studies r prostate data R prostate data have found that obesity increases the risk of death in advanced cancers. Studies have also concluded that obesity decreases the risk that a cancer will be low-grade if it R prostate data does occur. Agent Orange Exposure to Agent Orange, a chemical weapon used in the Vietnam war, may possibly be linked to the development of more aggressive types of cancer, but the extent of this has not been confirmed. This condition is known as Benign Prostatic Hyperplasia (or prostate adenoma) because it refers to the non-malignant growth of prostatic tissue R prostate data in men from middle age onwards. In a young man, the prostate gland is at an almost undetectable rudimentary stage, and spreads across the coating of the urinary tract like a cluster of seeds. However, during puberty, R prostate data its form begins to change due to R prostate data r prostate data the increased production of the testosterone and dihydrotestosterone hormones. Testosterone causes the "seeds", called acini, to germinate and grow. In adult life, due R prostate data to this growth and proliferation, these small R prostate data glandular structures can give rise to obstructive symptoms associated with urinary flow disorders. Benign Prostatic Hyperplasia is one of the most common diseases in men and is considered to be part of the physiological ageing process. The incidence of this disease is 51% in men aged 60 to 69, and between r prostate data 75% and 90% in octogenarians. Symptomatology Although the definition of BPH encapsulates the enlargement of the prostate and the mechanical obstruction of the flow of urine, a direct relationship between the volume of hyperplasia and the intensity of symptoms is not always present. Very enlarged prostates do not always cause symptoms and other less enlarged Prostate 1 per day organs can be a r prostate data source of intense discomfort.

The symptoms of Benign R prostate data Prostatic Hyperplasia can be divided into two categories: obstructive and irritative. Obstructive symptoms Weak R prostate data r prostate data and/or intermittent flow of urine. Double voiding (urinating for a second time within a period of 2 hours). Irritative symptoms Polyuria, or r prostate data increased frequency of urination. Nocturia, or the need r prostate data to urinate frequently during the night. Treatment of Benign Prostatic Hyperplasia Early diagnosis of Benign R prostate data Prostatic Hyperplasia is essential to avoid complications R prostate data such as urinary tract infections, damage to the kidneys or bladder, bladder stones and incontinence. The r prostate data treatment for BPH will be determined by the potential for the existence of these secondary processes that derive from urinary obstruction, along with the patient’s level of discomfort Medical treatment In patients with mild or r prostate data moderate symptoms, a pharmacological treatment can be administered that is based on alpha-blockers and alpha-reductase r prostate data inhibitors, which can help to improve urinary flow.





Stage x prostate cancer

Prostate wiki

Stage 7 prostate cancer survival rate

Prostate 60cc

02.04.2018 - PrinceSSka_OF_Tears

Most prostate cancers grow slowly and don’t.

02.04.2018 - BRIQADIR

Cancer Prostate cancer often does not cause.

Cilexin